Introduction: BLP25 liposome vaccine (L-BLP25) is an innovative therapeutic cancer
vaccine designed to induce an immune response resulting in elimination of tumor cells …

Background We sought to determine whether the substantial benefits of topical nitroglycerin
with first-line, platinum-based, doublet chemotherapy in advanced nonsmall-cell lung cancer …

Purpose This study aimed to determine the safety and efficacy of a 6-month supervised
exercise program in a pancreatic cancer patient undergoing adjuvant treatment. Methods A …

In this phase II, single arm trial (ACTRN12617000720314), we investigate if alternating
osimertinib and gefitinib would delay the development of resistance to osimertinib in …

Introduction Evidence regarding the role of exercise in pancreatic cancer (PanCa) is limited
and is derived exclusively under tightly controlled research conditions. This study aimed to …

Introduction Exercise is emerging as a therapy in oncology for its physical and psychosocial
benefits and potential effects on chemotherapy tolerability and efficacy. However, evidence …

Stage III non–small cell lung cancer (NSCLC) makes up a third of all NSCLC cases and is
potentially curable. Despite this 5‐year survival rates remain between 15% and 20% with …

We report two cases of the rare neurological paraneoplastic syndrome, limbic encephalitis,
as the initial presentation of small cell lung cancer. The first case responded to treatment of …

Methods: An electronic database search was carried out to identify all cases of locally
advanced pancreatic cancer treated between 2 institutions. Case records, pathology …

Background: Patients with solid tumour are predisposed to influenza, making them an
appropriate target population for the annual flu vaccine program. On the other hand, this …